Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference52 articles.
1. Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features;Harabuchi;Int. J. Clin. Oncol.,2009
2. Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature;Wang;BMC Urol.,2017
3. Efficacy of gemcitabine as salvage therapy for relapsed and refractory aggressive non-hodgkin lymphoma;Zlotnick;Acta Haematol.,2019
4. [Chemotherapy using gemcitabine hydrochloride for malignant lymphoma], Gan to kagaku ryoho;Asou;Cancer Chemotherapy,2013
5. Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory hodgkin lymphoma: final results of a multicenter phase II study;Santoro;J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol.,2016
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment;Signal Transduction and Targeted Therapy;2023-12-27
2. Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T‐cell lymphoma;Cancer Medicine;2023-10-30
3. The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2;Immunity & Ageing;2023-07-05
4. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application;Molecules;2023-04-17
5. Thymosin α-1 in cancer therapy: Immunoregulation and potential applications;International Immunopharmacology;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3